DK0802796T3 - Kyllingeanæmimiddel-slagtekyllingevaccine - Google Patents

Kyllingeanæmimiddel-slagtekyllingevaccine

Info

Publication number
DK0802796T3
DK0802796T3 DK96900947T DK96900947T DK0802796T3 DK 0802796 T3 DK0802796 T3 DK 0802796T3 DK 96900947 T DK96900947 T DK 96900947T DK 96900947 T DK96900947 T DK 96900947T DK 0802796 T3 DK0802796 T3 DK 0802796T3
Authority
DK
Denmark
Prior art keywords
vaccine
kyllingeanæmimiddel
broiler
production losses
broilers
Prior art date
Application number
DK96900947T
Other languages
English (en)
Inventor
Carla Christina Schrier
Dijk Pieter Matthijs Van
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0802796T3 publication Critical patent/DK0802796T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK96900947T 1995-01-06 1996-01-04 Kyllingeanæmimiddel-slagtekyllingevaccine DK0802796T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95200018 1995-01-06
PCT/EP1996/000122 WO1996020727A1 (en) 1995-01-06 1996-01-04 Chicken anaemia agent broiler vaccine

Publications (1)

Publication Number Publication Date
DK0802796T3 true DK0802796T3 (da) 2002-01-21

Family

ID=8219942

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96900947T DK0802796T3 (da) 1995-01-06 1996-01-04 Kyllingeanæmimiddel-slagtekyllingevaccine

Country Status (12)

Country Link
US (1) US6270770B1 (da)
EP (1) EP0802796B1 (da)
JP (1) JP4050312B2 (da)
AT (1) ATE206310T1 (da)
AU (1) AU4486096A (da)
BR (1) BR9606725A (da)
DE (1) DE69615656T2 (da)
DK (1) DK0802796T3 (da)
ES (1) ES2167536T3 (da)
MX (1) MX9705068A (da)
PT (1) PT802796E (da)
WO (1) WO1996020727A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070003508A1 (en) 2005-07-01 2007-01-04 Wooley Richard E Methods and compositions for promoting wound healing
US20040208842A1 (en) * 2001-09-18 2004-10-21 Ritchie Branson W. Antimicrobial cleansing compositions and methods of use
US20040151765A1 (en) * 2001-09-18 2004-08-05 Ritchie Branson W. Methods and compositions for wound management
US7217420B2 (en) * 2002-07-13 2007-05-15 The University Of Georgia Research Foundation, Inc. Mycoplasma gallisepticum formulation
US20070185202A1 (en) * 2004-03-03 2007-08-09 University Of Georgia Research Foundation, Inc. Methods and compositions for ophthalmic treatment of fungal and bacterial infections
US9056825B2 (en) 2010-10-13 2015-06-16 Celanese International Corporation Process for recovering halogen promoters and removing permanganate reducing compounds
CN106248932A (zh) * 2016-08-18 2016-12-21 山东新四维农业科技有限公司 一种用于优质中型青年蛋鸡的鉴别方法
CN115058522B (zh) * 2022-07-21 2023-06-13 江苏省家禽科学研究所 一种鉴定含有白洛克血缘的肉鸡品种的分子标记及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA918426B (en) 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic
US5686077A (en) * 1991-09-20 1997-11-11 Akzo Nobel N.V. Methods of immunization of poultry with vaccines against chicken anemia agent (CAA)
ZA927014B (en) 1991-09-20 1993-03-19 Akzo Nv Chicken anaemia agent vaccine.

Also Published As

Publication number Publication date
JP4050312B2 (ja) 2008-02-20
EP0802796B1 (en) 2001-10-04
DE69615656T2 (de) 2002-08-01
ATE206310T1 (de) 2001-10-15
WO1996020727A1 (en) 1996-07-11
MX9705068A (es) 1997-10-31
EP0802796A1 (en) 1997-10-29
US6270770B1 (en) 2001-08-07
AU4486096A (en) 1996-07-24
JPH10511945A (ja) 1998-11-17
PT802796E (pt) 2002-02-28
BR9606725A (pt) 1998-01-13
ES2167536T3 (es) 2002-05-16
DE69615656D1 (de) 2001-11-08

Similar Documents

Publication Publication Date Title
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
MX9204625A (es) Composicion farmaceutica para el tratamiento de una especie de mamifero, que sufre de deficiencia cardiaca congestiva.
BG103740A (en) Phytostyrene composition for the prevention of the alzheimer's disease
BG100960A (bg) Дозирани форми с контролирано освобождаване на азитромицин
DE69131014D1 (de) Rekombinante avirulente salmonella antifruchtbarkeitsimpfstoffe
FI912636L (fi) Energiproduktionsanordning, speciellt vid fartyg med propellerdriven driftsanordning, foersedd med solgenerator.
DE69334035D1 (de) Verfahren zur vorbeugung von nmda-rezeptor vermittelten neuronalen schäden
GB0109146D0 (en) Treatment of type 2 diabetes
CO4950529A1 (es) Dihidropirimidinas y productos que las contienen
FI922239A0 (fi) Modifierad amorf kiseloxid, foerfarande foer dess framstaellning och anti-blockmedel, daer den ingaor.
EA200400455A1 (ru) Способ приготовления быстрорастворимой дозировочной формы
DE59009354D1 (de) Zahnärztlicher Patientenstuhl.
ES2170143T3 (es) Composiciones que comprenden halofantrina en una forma especial.
ATE206310T1 (de) Aviären infektiösen anämie mastgeflügel impfstoff
DE59204452D1 (de) Zahnwurzelimplantat.
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
DE69107150D1 (de) 1,1,1-Trishdroxyphenyläthanacrylate.
HRP20000400B1 (hr) Transmukozni pripravci levosimendana
KR930702004A (ko) 세파로스포란 산 유도체를 함유하는 정제를 제조하기 위한 직접 압축 방법
FR2674755B1 (fr) Nouvelles compositions medicamenteuses immunostimulatrices.
FR2715304B1 (fr) Vaccin anti-allergique.
AU2003273884A1 (en) Chicken astrovirus type 2
DE59204210D1 (de) Zahnärztliches handstück.
DE69930952D1 (de) Gesteuerte freisetzung von antidepressiva
FI972389A0 (fi) Uusi menetelmä ranitidiinin valmistamiseksi